Xeris Pharmaceuticals's market cap is currently $1.29B. The company's EPS TTM is $-0.01; its P/E ratio is ―; Xeris Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 23
Dec 23
Dec 23
Currency in USD
Xeris Pharmaceuticals Earnings and Revenue History
